Europe has been watching America’s relentless fight over abortion and has, out of indiscretion and greed, apparently stepped in to offer its services. The elusive company “Aid Access” facilitates abortion services for women following online consultations, so long as they are very early in their pregnancy, less than nine weeks. This has been going on for several months and has prompted a Food and Drug Administration investigation. Despite FDA concerns, abortion advocates in the U.S. support the company and the abortion pill mail-order concept.

According to their website, Aid Access claims it is a “private initiative by a committed team of medical doctors and long term abortion rights activists.... The aim of the website and service is to create social justice and improve the health status and human rights of women who cannot access locally available abortion services.” The company claims that if a woman completes her consultation and is indeed less than nine weeks pregnant, mifepristone (basically RU-486) and misoprostol will be delivered by mail for about $100 — although they offer help in the event that a woman can’t afford the cost. “An abortion with pills can be done safely at home as long as you have good information and access to emergency care in the rare case of complications,” the website claims. It’s unclear how the company ensures that a woman is just nine weeks pregnant, rather than say, 13 weeks or more. Women can easily misdiagnose how far along they are, just by failing to know the date of their last period.

However, the FDA has begun investigating the company because both of those drugs offered together could have dangerous side effects. The FDA warns against buying mifepristone over the Internet because there are few safeguards in place. The drug essentially induces a woman to miscarry, or abort, a baby. This week, the FDA said it is trying to determine what Aid Access is doing "to assess potential violations of U.S. law."

While it’s not surprising that abortion advocates would be in favor of this, it’s sad they would put the health of women potentially at risk to favor yet another method to provide abortions.

The Atlantic's Olga Khazan dubbed a similar service “safe,” despite the FDA's warnings. Unsurprisingly, Cosmopolitan is also excited for this company’s efforts to promote abortion in the U.S.

Mail-order abortion is an unnecessary intervention in the abortion debate in America and a potentially unsafe one at that. It should not be encouraged, praised, or reported as safe while the FDA is investigating the company’s protocols.

Nicole Russell (@russell_nm) is a contributor to the Washington Examiner's Beltway Confidential blog. She is a journalist who previously worked in Republican politics in Minnesota.